These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2096982)

  • 1. Merozoite selection of erythrocytes by age and the induction of protective immunity.
    Brown KN; Carlsson J; Jarra W
    Blood Cells; 1990; 16(2-3):313-8. PubMed ID: 2096982
    [No Abstract]   [Full Text] [Related]  

  • 2. Towards a malaria vaccine: what is in sight?
    del Giudice G
    Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional analysis of Plasmodium falciparum merozoite antigens: implications for erythrocyte invasion and vaccine development.
    Cowman AF; Baldi DL; Duraisingh M; Healer J; Mills KE; O'Donnell RA; Thompson J; Triglia T; Wickham ME; Crabb BS
    Philos Trans R Soc Lond B Biol Sci; 2002 Jan; 357(1417):25-33. PubMed ID: 11839179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current state of the studies of malaria vaccine].
    Dzbeński TH
    Przegl Epidemiol; 1990; 44(3):173-8. PubMed ID: 2084799
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of malaria vaccines.
    Perrin LH; Simitsek P; Srivastava I
    Trop Geogr Med; 1988 Jul; 40(3):S6-21. PubMed ID: 3055567
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of protective immunity against experimental infection with malaria using synthetic peptides.
    Patarroyo ME; Romero P; Torres ML; Clavijo P; Moreno A; Martínez A; Rodríguez R; Guzman F; Cabezas E
    Nature; 1987 Aug 13-19; 328(6131):629-32. PubMed ID: 3302727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of asexual blood stage malaria vaccines.
    Kidson C
    Southeast Asian J Trop Med Public Health; 1988 Sep; 19(3):391-6. PubMed ID: 3064322
    [No Abstract]   [Full Text] [Related]  

  • 8. Induction of protective immunity to malaria.
    Anders RF; Brown GV; Coppel RL; Kemp DJ
    Lepr Rev; 1986 Dec; 57 Suppl 2():245-53. PubMed ID: 3553798
    [No Abstract]   [Full Text] [Related]  

  • 9. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.
    Patarroyo ME; Amador R; Clavijo P; Moreno A; Guzman F; Romero P; Tascon R; Franco A; Murillo LA; Ponton G
    Nature; 1988 Mar; 332(6160):158-61. PubMed ID: 2450281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential vaccine antigens of the asexual blood-stages of Plasmodium falciparum.
    Anders RF; Brown GV; Coppel RL; Stahl HD; Bianco AE; Favaloro JM; Crewther PE; Culvenor JG; Kemp DJ
    Dev Biol Stand; 1985; 62():81-9. PubMed ID: 2422079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunologic prevention of malaria].
    Wagner WH
    Med Monatsschr Pharm; 1990 Jul; 13(7):209-15. PubMed ID: 1695990
    [No Abstract]   [Full Text] [Related]  

  • 12. Variant merozoite protein expression is associated with erythrocyte invasion phenotypes in Plasmodium falciparum isolates from Tanzania.
    Bei AK; Membi CD; Rayner JC; Mubi M; Ngasala B; Sultan AA; Premji Z; Duraisingh MT
    Mol Biochem Parasitol; 2007 May; 153(1):66-71. PubMed ID: 17303262
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for a 6.5-day minimum exoerythrocytic cycle for Plasmodium falciparum in humans and confirmation that immunization with a synthetic peptide representative of a region of the circumsporozoite protein retards infection.
    Murphy JR; Baqar S; Davis JR; Herrington DA; Clyde DF
    J Clin Microbiol; 1989 Jul; 27(7):1434-7. PubMed ID: 2671011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of CD4+CD45RO+ T lymphocytes producing IL-4 in response to antigens on Plasmodium falciparum erythrocytes: an in vitro correlate of protective immunity induced with attenuated Plasmodium falciparum sporozoites.
    Bergmann ES; Ballou RW; Krzych U
    Cell Immunol; 1997 Sep; 180(2):143-52. PubMed ID: 9341744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targets of protective antibodies to malaria during pregnancy.
    Beeson JG; Rogerson SJ; Elliott SR; Duffy MF
    J Infect Dis; 2005 Nov; 192(9):1647-50. PubMed ID: 16206081
    [No Abstract]   [Full Text] [Related]  

  • 16. Conserved polypeptides of Plasmodium falciparum as malaria vaccine candidates?
    Herrera S; Herrera MA; Clavijo C; Corredor A; Certa U
    Acta Leiden; 1991; 60(1):107-10. PubMed ID: 1820697
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A.
    Sharling L; Enevold A; Sowa KM; Staalsoe T; Arnot DE
    Malar J; 2004 Sep; 3():31. PubMed ID: 15350207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The precursor to major merozoite surface antigens: structure and role in immunity.
    Holder AA
    Prog Allergy; 1988; 41():72-97. PubMed ID: 3043424
    [No Abstract]   [Full Text] [Related]  

  • 19. Parasitology. Malaria--from infants to genomics to vaccines.
    Long CA; Hoffman SL
    Science; 2002 Jul; 297(5580):345-7. PubMed ID: 12130768
    [No Abstract]   [Full Text] [Related]  

  • 20. Is the increased erythrophagocytosis of malaria-infected variant erythrocytes due to early expression of normal senescence markers or to the formation of new and specific removal markers?
    Arese P; Turrini F; Bussolino F
    Blood Cells; 1990; 16(2-3):598-601. PubMed ID: 2096987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.